Metformin and Camzyos drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metformin (metformin hydrochloride) and Camzyos (mavacamten). Common drug interactions include dyspnoea among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Metformin and Camzyos. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

What is Camzyos?

Camzyos has active ingredients of mavacamten. eHealthMe is studying from 1,625 Camzyos users. Check the latest studies of Camzyos.



On May, 25, 2026

41 people who take Metformin and Camzyos together, and have interactions are studied.

Metformin and Camzyos drug interactions.

What are the common drug interactions of Metformin and Camzyos, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Ejection fraction decreased (systolic heart failure)
  4. Muscular weakness (muscle weakness)
  5. Myalgia (muscle pain)
  6. Myositis (inflammation of the muscles)
  7. Dizziness
  8. Asthenia (weakness)
  9. Confusional state
  10. Cystitis (inflammation of the wall of the bladder)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Hypotension (abnormally low blood pressure)
  4. Increased appetite
  5. Nephrolithiasis (calculi in the kidneys)
  6. Oedema peripheral (superficial swelling)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Vertigo
  10. Vomiting

What are the common drug interactions of Metformin and Camzyos, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Syncope (loss of consciousness with an inability to maintain postural tone)

40-49:

  1. Chest discomfort
  2. Dizziness
  3. Heart rate decreased
  4. Hypotension (abnormally low blood pressure)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Vertigo

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blood magnesium decreased
  4. Dizziness
  5. Abdominal discomfort
  6. Blood pressure increased
  7. Constipation
  8. Fatigue (feeling of tiredness)
  9. Increased appetite
  10. Nephrolithiasis (calculi in the kidneys)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Nausea (feeling of having an urge to vomit)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Upper respiratory tract infection
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Adverse event
  8. Arthralgia (joint pain)
  9. Blood disorder
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 37 people, 90.24%
  2. Pain: 5 people, 12.20%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.76%
  4. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 7.32%
  5. Stress And Anxiety: 3 people, 7.32%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Metformin and Camzyos?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metformin and Camzyos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Camzyos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Camzyos and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride and mavacamten (the active ingredients of Metformin and Camzyos, respectively), and Metformin and Camzyos (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: